Skip to main content

Table 1 Baseline subjects’ characteristics according to randomization

From: Randomized outcome trial of nutrient-enriched formula and neurodevelopment outcome in preterm infants

 

AGA

SGA

 

Treatment B

Treatment A

Treatment B

Treatment A

n = 52

n = 56

n = 35

n = 38

Gestational age (weeks)

28.9 ± 1.9

29 ± 1.7

31.4 ± 1.9

31.6 ± 1.9

Birth weight (g)

1146 ± 223

1197 ± 204

1103.4 ± 239

1129 ± 304

Birth length (cm)

36.5 ± 3

37.4 ± 2.8

36.5 ± 3.4

36.5 ± 3.8

Birth HC° (cm)

26.4 ± 2

27.1 ± 2.2

27 ± 2.4

27.2 ± 2.4

Twins n (%)

25 (48)

23 (41)

12 (34)

11 (29)

Males n (%)

26 (50)

31 (60)

17 (49)

21 (55)

Abnormal MRI n (%)

5 (10)

2 (4)

4 (11)

5 (13)

Protein intake (g/kg/day)

2.79 ± 0.42*

2.24 ± 0.49

2.94 ± 0.48*

2.26 ± 0.36

(Term-6 months corrected age)

Energy intake (kcal/kg/day)

109.6 ± 14.3

108.8 ± 17.6

110.2 ± 24.7

108.6 ± 12.7

(Term-6 months corrected age)

Maternal education >13 years

24 (46)

23 (41)

18 (51)

18 (47)

  1. °HC = head circumference.
  2. *P < 0.001.
  3. Data were analysed using the independent samples T test or the chi square test and comparisons were made between AGA infants fed enriched formula vs AGA infants fed standard formula and between SGA infants fed enriched formula vs SGA infants fed standard formula.